Our staff and board have a strong commitment to serving the many constituents of our organization. But first and foremost, they focus their energies on those who take advantage of our programs and services.
Andrea is new to the bleeding disorder community and has already begun to dig in! She brings over 15 years of experience working for large non-profit health organizations. Most recently, she served as a Senior Director for The Leukemia & Lymphoma Society. She also has done extensive development work for the American Heart Association, as well as the American Cancer Society. Prior to entering into the non-profit world, Andrea worked in sales and marketing management for some major corporations: AT&T, Experian and Bank of America among them. Andrea wants you to know that she was “thrilled to accept this position and will strive to make HFNC a wonderful and caring home for our community”. She looks forward to meeting each and every one of you when COVID-19 allows us to be together once more. Andrea is married to her husband, Mark and is the proud “bonus mom” to 3 wonderful young men, Joe, Jared and Brian. She’s fun-loving “Grandma ‘Drea” to 5 grandchildren. She and Mark enjoy spending their time traveling to America’s National Parks in the lower 48 and to Alaska. Please join the Board of Directors and staff at HFNC in welcoming her.
Ashley Gregory is a woman with a bleeding disorder and parent of children with bleeding disorders. She has been involved in the community since 2014, continuously attending national and local events to meet stakeholders, gather information and develop relevant programming and advocacy. She volunteered for many events and projects for which she was awarded volunteer of the year for two years (2015, 2016) and was officially hired by HFNC in spring 2019. Currently, she serves as Director of FAIR Time for Women and is Vice President of the Board of Danny's Dose. Ashley wants to get to know you, your family and your needs and encourages you to let her know what is on your mind. In her spare time, Ashley can be found in her seaside town creating culinary delights, walking by the ocean, listening to podcasts, watching sunsets and enjoying her adult children and her hairless cat, Kit.
Randall G. Curtis,MBA President (Member 2022-)
Randall G. Curtis, MBA Past Board Member. Bleeding disorders advocate for the last 40 years. Person born with hemophilia.
Randall Curtis has a Bachelor of Science in genetics and an MBA in computer information systems. He has been developing data collection systems for blood disorders since 1984. Now that he has retired from public service, he devotes his time to collecting data on the Hematology Utilization Group Studies (HUGS), the Patient Reported Outcomes, Burdens and Experiences (PROBE) study and the Cost of Hemophilia Socioeconomic Survey (CHESS) projects. Mr. Curtis also serves on the board of directors for the Center for Inherited Bleeding Disorders, is the past president of the Hemophilia Council of California and has served on the HFNC Board of Directors off and on since 1979. His policy work includes the American Thrombosis & Hemostasis Network (ATHN), the National Hemophilia Foundation MASAC Pain Group and the Pacific Sickle Cell Regional Collaborative Policy Working Group.
Randy and Jackie have two sons and four grandchildren. Now that Randy and Jackie are empty nesters, they are trying to visit all of the National Parks.
Dawn Pollard, Vice President
Vice President of the Board of Directors, Former Board President with over 30 years in biotech HR. Sibling of two brothers with hemophilia and diagnosed carrier.
Derek Sim, Secretary
Secretary - Scientist involved in drug development for hematological disorders for the last 20 years, including experience in developing hemophilia therapies.
Anita Bawa, Treasurer (Board Member 2022-_
Anita Bawa, Executive Director and Quality Site Head at Allogene - Over 25 years’ experience in blood banking, biotech manufacturing, cell and gene therapy and previously worked on Factor VIII products.
Anita received her BA in Business from St. Mary’s College, followed by an MBA from the University of San Francisco and which she earned while working full time. Anita has diverse industry experience spanning a 20+ year career. She has held roles of increasing responsibility in Manufacturing, Quality Control Laboratory, and Quality Operations at Blood Bank, Genentech, Bayer and Sutro Biopharma and has lead organizations up to 200 people.
Anita joined Allogene in September 2019. In her role as Quality Site Head, Anita has done an exceptional job developing the Quality Team and providing leadership and direction to establish core processes across quality operations, site quality systems and validation, microbiology and environmental monitoring and raw material qualification.
Anita is recognized and appreciated as a decisive and pragmatic leader. She has strong technical background in biotech and GMP operations. She is goal oriented and get things done.
Anita is married and have two children (grown up) and enjoy traveling, reading, and spending time with family and friends.
As a person with Severe Hemophilia A, Marc is incredibly excited to join the Northern California bleeding disorders community after relocating from New York in July 2023. Marc has held professional positions in bleeding disorders; first on the community side as the Programs and Events Manager for the New York City Hemophilia Chapter from 2018-2020 and then on the industry side as the Hemophilia Community Liaison (Northeast Region) for Novo Nordisk from 2020-2023.
In addition to his own personal experience living with hemophilia, serving a large and highly diverse bleeding disorder population in both professional roles has helped him develop a nuanced and multi-faceted view of the evolving needs of the bleeding disorder community. Marc is looking forward to utilizing his skills and experience for the benefit of the Northern California bleeding disorders community and he is truly grateful for the opportunity to be on the HFNC Board.
Since leaving the professional side of bleeding disorders in January 2023, Marc continues his career in Patient Affairs within the pharmaceutical/biotechnology sector; specializing in rare disease populations.
Active in Fresno area hemophilia auxiliary activities for 25 years, pharmacy owner for 33 years and currently a farmer/rancher in Sanger, CA. I am a person with hemophilia as well as father of a 30 year old son with hemophilia.
Involved in bleeding disorders for over 35 years as a member of HTC team, industry executive, HCC board president, and current rare disease consultant.
Board member since 2021, also board member for the Hemophilia Council of California, Camp Hemotion JC/AC co-Coordinator, UCSF Adult HTC Social Worker